Beijing Succeeder Technology Inc. (SHA:688338)

Market Cap	3.01B
Revenue (ttm)	275.02M
Net Income (ttm)	93.90M
Shares Out	103.97M
EPS (ttm)	1.14
PE Ratio	25.47
Forward PE	24.36
Dividend	0.33 (1.14%)
Ex-Dividend Date	Jun 12, 2025

Volume	1,169,615
Average Volume	1,154,678
Open	29.07
Previous Close	29.03
Day's Range	28.80 - 29.20
52-Week Range	21.28 - 29.48
Beta	0.57
RSI	76.31
Earnings Date	Apr 24, 2026

About SHA:688338

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding disorders. Beijing Succeeder Technology...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 274
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688338

Financial Performance

In 2024, SHA:688338's revenue was 305.87 million, an increase of 11.03% compared to the previous year's 275.49 million. Earnings were 113.00 million, a decrease of -3.35%.